key: cord-0925859-o9rxomhg
authors: Ronzio, Luca; Cabitza, Federico; Barbaro, Alessandro; Banfi, Giuseppe
title: Has the Flood Entered the Basement? A Systematic Literature Review about Machine Learning in Laboratory Medicine
date: 2021-02-22
journal: Diagnostics (Basel)
DOI: 10.3390/diagnostics11020372
sha: ed05a43f6111f53bd222e0bcaad391beb17e5def
doc_id: 925859
cord_uid: o9rxomhg

This article presents a systematic literature review that expands and updates a previous review on the application of machine learning to laboratory medicine. We used Scopus and PubMed to collect, select and analyse the papers published from 2017 to the present in order to highlight the main studies that have applied machine learning techniques to haematochemical parameters and to review their diagnostic and prognostic performance. In doing so, we aim to address the question we asked three years ago about the potential of these techniques in laboratory medicine and the need to leverage a tool that was still under-utilised at that time.

In 2018, we published a survey of the existing literature on the use of machine learning (ML) techniques in laboratory medicine, as reported in studies published from 2007 to 2017 [1] . In that effort, we noticed that very few works reported on the use of ML techniques to address either diagnostic or prognostic tasks, leveraging a large amount data extracted from laboratory tests, especially in comparison to the number of studies reporting on the application of ML techniques to diagnostic imaging and instrumental examinations. We summarised this seeming paradox, claiming that the "flood" of works applying ML to laboratory medicine had not yet occurred. Three years later, this current review aims to obtain an up-to-date picture of the body of work reporting on the use of ML applications in laboratory medicine that were published from 2018 to 2020.

After our first review, in 2019, Naugler and Church [2] discussed the innovative potential of the current techniques of artificial intelligence (AI) in laboratory medicine, and they highlighted the significant amount of attention being paid to and the increased expectations associated with cognitive computing from multiple stakeholders and standpoints in the medical community. That interest has constantly increased since then: in 2019, a MEDLINE search using the expression "artificial intelligence" as the query would approximately return 25,000 papers; in contrast, in late 2020, the same query yielded almost 110,000 articles, more than a four-fold increase within one year [3] .

The interest in ML is not confined to the academic world, given the increasing number of AI-based algorithms approved by the United States Food and Drug Administration (FDA) [4] . Out of 68 models approved by the FDA, 61 were cleared during the last three years, especially for radiology applications, with 34 algorithms that can be traced back to this medical field. Cardiology, with 18 models, is another area where some form of AI technology is proposed more frequently [5] .

Conversely, laboratory medicine is not yet very well represented in this context. Only seven models have been registered to date: one of these is an application to detect urinary tract infections [6] and another is a system capable of predicting blood glucose changes over time [7] .

In this article, we address the academic production and reporting of ML studies as a natural follow-up of our first review. While in our first review we provided an introduction to the ML approach for a medical readership, here, we only mention the main elements and definitions (interested readers can refer to Reference [1] or [8] [9] [10] for more details).

ML is an umbrella term for a number of computational and statistical techniques that can be used to create a medical AI, which is a system that is capable of automating, or computationally supporting, a complex medical task, such as diagnosis, prognosis or treatment planning and monitoring [1, 10, 11] . Specific definitions of ML usually vary according to the field and area of interest of their source. The definition of ML that we want to address in this paper is a combination of two recent contributions by Wang, Summers and Obermeyer [12, 13] : ML is "the study of how computer algorithms can 'learn' complex relationships or patterns from empirical data and produce (mathematical) models linking a large number of covariates to some target variable of interest" [8] . Although this definition mentions the common term, 'learn', its meaning should be considered as an evocative way to denote the iterative optimisation of a mathematical model (or function), rather than something related to the human ability to learn and acquire new knowledge and skills [10] . The field of computer science is full of metaphorical expressions that refer to human capabilities that do not have a real counterpart in the computational field [9] , and ML is no exception, as it includes the term deep learning (DL), which denotes a subset of ML techniques that employ a class of mathematical models known as artificial neural networks (ANNs). While DL models exhibit a generally high accuracy in diagnostic tasks based on digital imaging (such as Computed tomography (CT), X-rays and Magnetic resonance imaging (MRI)), their deepness refers to the multi-layered nature of the computational models and not some deep comprehension of the input received, or any insight achieved. In fact, for tabular and numerical data, such as data obtained from laboratory exams, other ML methods, including logistic regression, have been found to be preferrable [14] , especially in terms of their higher generalisability and interpretability [15] .

The three main tasks executed by ML models are classification, regression and clustering. Classification, as the word infers, refers to the identification, for each record given to the model as input, of its target class or correct category. Regression refers to the estimation of the correct value of a continuous variable. Clustering is an approach that allows one to group different records together by associating them to groups (i.e., clusters) on the basis of their similarities.

In August 2020, we performed the searches reported in Figure 1 on PubMed Central ® (PMC), which is a free archive of biomedical and life sciences journal literature managed by the United States National Institutes of Health's National Library of Medicine, and Scopus, a comprehensive abstract and citation database curated by Elsevier. The query we chose is reported in Appendix A.

Our objective was to find the published articles in which their authors claimed to have used ML for a task connected to laboratory medicine. A first selection of papers was obtained by searching for specific keywords in the titles and abstracts only, and, when deemed necessary, on the content of the whole manuscript. With respect to the indications provided by Salvador-Olivan [16] , the search query included the base form of the words, and particular attention was paid to the use of Boolean operators or parenthesis. Our inclusion criteria were:

•

The study was written in English.

The study was published after March 2017.

The study mentioned at least one known ML technique.

The study was available online as a full research article or review. Our objective was to find the published articles in which their authors claimed to have used ML for a task connected to laboratory medicine. A first selection of papers was obtained by searching for specific keywords in the titles and abstracts only, and, when deemed necessary, on the content of the whole manuscript. With respect to the indications provided by Salvador-Olivan [16] , the search query included the base form of the words, and particular attention was paid to the use of Boolean operators or parenthesis. Our inclusion criteria were: 

The study was written in English. 

The study was published after March 2017. 

The study mentioned at least one known ML technique. 

The study was available online as a full research article or review. Studies that did not meet all these criteria were excluded. Then, we performed a qualitative analysis of the papers that were obtained from this first selection process. Subthemes for each article were defined and relevant labels were assigned following the Grounded Theory approach [17] . The subthemes were then organised into main themes, in order to avoid overlap and redundancy. If a new subtheme emerged, all the papers were re-evaluated to apply the new subtheme in an iterative way, known as the constant comparison method [17] .

For each paper, we extracted and summarised the following information: the medical domain the study belonged to, the kind of cohort involved, the purpose of the application, the ML technique applied and the evaluation metrics used to assess the model's performance.

Our research produced 127 results from Scopus and 47 from PubMed. Among these, 23 were duplicates, so a total of 151 unique articles were retrieved. After reviewing the titles and abstracts, 102 papers were excluded. Four more papers were ignored because they were not written in English and one was rejected because the full text was not available. Finally, 44 articles were analysed, and the main characteristics of each are reported in Tables 1 and 2 . Studies that did not meet all these criteria were excluded. Then, we performed a qualitative analysis of the papers that were obtained from this first selection process. Subthemes for each article were defined and relevant labels were assigned following the Grounded Theory approach [17] . The subthemes were then organised into main themes, in order to avoid overlap and redundancy. If a new subtheme emerged, all the papers were re-evaluated to apply the new subtheme in an iterative way, known as the constant comparison method [17] .

For each paper, we extracted and summarised the following information: the medical domain the study belonged to, the kind of cohort involved, the purpose of the application, the ML technique applied and the evaluation metrics used to assess the model's performance.

Our research produced 127 results from Scopus and 47 from PubMed. Among these, 23 were duplicates, so a total of 151 unique articles were retrieved. After reviewing the titles and abstracts, 102 papers were excluded. Four more papers were ignored because they were not written in English and one was rejected because the full text was not available. Finally, 44 articles were analysed, and the main characteristics of each are reported in Tables 1 and 2 . Evaluate the feasibility of predictive modelling of postoperative hyponatremia after pituitary tumour surgery using preoperative available variables Re * It was chosen as the most useful, although it was not the best performer; ** Different models were trained with a different number of features; *** A comparison of the ML models was not made; NA: Not available; NE: Not evaluable (meaning not pertinent). For all the other abbreviations, see Appendix B. All the papers included in the review were published from 2017 to 2020, as shown in Tables 1 and 2 . Notably, almost three-quarters of these studies (n = 31, 71%) were published in the last two years.

From a study design standpoint, virtually all of the papers used a retrospective approach (96%). Table 3 and Figure 2 . depict the number of articles divided by medical specialty in association with laboratory medicine. Table 3 . Analysed articles based on year of publication and medical specialty. All the papers included in the review were published from 2017 to 2020, as shown in Tables 1 and 2 . Notably, almost three-quarters of these studies (n = 31, 71%) were published in the last two years.

From a study design standpoint, virtually all of the papers used a retrospective approach (96%). Table 3 and Figure 2 . depict the number of articles divided by medical specialty in association with laboratory medicine. The prognostic task was the one that was most often represented (48%), followed by the diagnostic task (30%): 18% of the articles had a research task and 4.6% had a therapy task. When included, detection (64%) was the type of analysis most often conducted, followed by regression (16%) and characterisation (9.1%).

Most of the studies proposed multiple comparisons between several ML models, while only eight proposed a simpler comparison between two models. The models that were tested more frequently are (in decreasing order): models based on decision trees (DTs), such as random forest (RF), regression models, Ensemble models, support vector The prognostic task was the one that was most often represented (48%), followed by the diagnostic task (30%): 18% of the articles had a research task and 4.6% had a therapy task. When included, detection (64%) was the type of analysis most often conducted, followed by regression (16%) and characterisation (9.1%).

Most of the studies proposed multiple comparisons between several ML models, while only eight proposed a simpler comparison between two models. The models that were tested more frequently are (in decreasing order): models based on decision trees (DTs), such as random forest (RF), regression models, Ensemble models, support vector machines (SVMs) and DL. If we only consider the best performing models, or those specifically recommended by the authors, the trees family of models (especially RF and DT), Ensembles (e.g., XGBoost) and DL models represent the majority, as shown in Figure 3 . machines (SVMs) and DL. If we only consider the best performing models, or those specifically recommended by the authors, the trees family of models (especially RF and DT), Ensembles (e.g., XGBoost) and DL models represent the majority, as shown in Figure 3 . Given the non-homogeneity of the model tasks, many metrics were used. Of those, area under the receiver operating curve (AUROC), sensitivity and specificity, F-score, positive predictive value (PPV) and negative predictive value (NPV) were the metrics most frequently adopted and reported.

As this is a systematic review that does not address a single clinical problem, we decided to not describe the articles by grouping them within macro-arguments, as other authors did in their narrative reviews (see References [62, 63] ). Instead, we will report one single model for each medical specialty, chosen on the basis of its potential clinical implications from the most recent and the most relevant studies considered in our survey.

Heart failure and the best features for predicting the outcome of patients suffering from this disease were the topics of the article from Chicco and Jurman [50] . They studied 299 patient records containing 13 features (clinical, body and lifestyle information) to predict the death or survival rates within 130 days. Ten different ML models-linear regression, RF, one rule, DT, ANN, two SVMs, k-nearest neighbours (KNN), naïve Bayes (NB) and gradient boosting (GB)-were trained and validated on the respective sets using all 13 predictors. On the testing set, RF outperformed all the other methods in terms of the Matthew correlation coefficient (MCC), which was the most relevant for the authors, obtaining an MCC of +0.384, and in terms of accuracy (0.740) and AUROC (0.800). Subsequently, from a series of univariate analysis and Gini impurity (from RF), the authors determined that serum creatinine and ejection fraction were the most important features for the outcome prediction for all the methods. They again trained three ML algorithms (RF, GB, SVM radial) using only these two features and obtained a better result than they achieved the first time. The second time, the best performer (again RF) obtained an MCC of +0.418, and an accuracy of 0.585, but a lower AUROC than GB (0.698 vs 0.792). Finally, Given the non-homogeneity of the model tasks, many metrics were used. Of those, area under the receiver operating curve (AUROC), sensitivity and specificity, F-score, positive predictive value (PPV) and negative predictive value (NPV) were the metrics most frequently adopted and reported.

As this is a systematic review that does not address a single clinical problem, we decided to not describe the articles by grouping them within macro-arguments, as other authors did in their narrative reviews (see References [62, 63] ). Instead, we will report one single model for each medical specialty, chosen on the basis of its potential clinical implications from the most recent and the most relevant studies considered in our survey.

Heart failure and the best features for predicting the outcome of patients suffering from this disease were the topics of the article from Chicco and Jurman [50] . They studied 299 patient records containing 13 features (clinical, body and lifestyle information) to predict the death or survival rates within 130 days. Ten different ML models-linear regression, RF, one rule, DT, ANN, two SVMs, k-nearest neighbours (KNN), naïve Bayes (NB) and gradient boosting (GB)-were trained and validated on the respective sets using all 13 predictors. On the testing set, RF outperformed all the other methods in terms of the Matthew correlation coefficient (MCC), which was the most relevant for the authors, obtaining an MCC of +0.384, and in terms of accuracy (0.740) and AUROC (0.800). Subsequently, from a series of univariate analysis and Gini impurity (from RF), the authors determined that serum creatinine and ejection fraction were the most important features for the outcome prediction for all the methods. They again trained three ML algorithms (RF, GB, SVM radial) using only these two features and obtained a better result than they achieved the first time. The second time, the best performer (again RF) obtained an MCC of +0.418, and an accuracy of 0.585, but a lower AUROC than GB (0.698 vs 0.792). Finally, the authors introduced the follow-up period (in months) as a temporal variable in a stratified logistic regression model, which obtained a better result than the model that only used creatinine and ejection fraction. Moreover, surprisingly, that model outperformed all the 

Timeliness is crucial, especially in the context of an emergency department. In Reference [47] , Lee et al. developed time adaptive models that predict adverse outcomes for febrile patients (T > 38 • ) using not only the values of lab tests (order status and results (OSR)), but also the simple request (order status only (OSO)). For this purpose, five ML algorithms (RF, SVM, logistic regression, ridge and elastic net regularization) were trained and validated using 9491 patients and variables chosen by experts. Of these, RF was the best performing ML model: it obtained an Area Under the Curve (AUC) of 0.80 (0.76-0.84) for OSO and 0.88 (0.85-0.91) for OSR. Comparing it with Modified Early Warning Score (MEWS), a reference algorithm used to predict the severity of a patient, the RF ML model showed an AUC improvement of 12% for OSO, meaning that the order pattern can be valuable in terms of predictions with a consistent saving time, and an AUC improvement of 20% for OSR. The RF and elastic net OSO models had Troponin I, creatine kinase and Creatine kinase isoenzyme MB (CK-MB) as the three top variables, while the lactic acid test was the most important variable for OSR.

In Reference [60] , Metsker et al. tackled the problem of predicting the risk of polyneuropathy in diabetic patients. To find the best way to handle missing data, they chose different solutions and obtained six different datasets. A T-distributed stochastic neighbour embedding (T-SNE) algorithm was applied to those datasets and data from 5425 patients were clustered in six subclasses. Five ML models (ANN, SVM, DT, linear regression and logistic regression) were trained first using 29 features and then 31 features (comorbidities were added to the previous 29). The performance on the testing set differed depending on whether the model was trained on 29 or 31 variables. Among the models with 29 variables, the best accuracy (0.7472) and best F1 score (0.7299) were obtained using the linear regression model. The logistic regression model had the best precision (0.6826), and ANN had the best sensitivity (0.8090). Among the models trained on all the variables, which obtained generally better results, ANN outperformed all the other models for every evaluation metric (sensitivity: 0.8152, F1 score 0.8064, accuracy: 0.8261, AUC: 0.8988) except for precision, in which SVM performed the best (0.8328). From the correlation analysis, it was then confirmed that both the patient's age and mean platelet volume have a positive correlation with polyneuropathy. Moreover, the DT model showed that the development of polyneuropathy is associated with the reduction in the relative number of neutrophils.

Roimi et al. [54] developed an ML model that can predict intensive care unit-acquired bloodstream infections (BSIs) among patients suspected of infection. They conducted a bicentre study using data from the Beth Israel Deaconess Medical Center (BIDCM) database system (MIMIC-III) and data from the Rambam Healthcare Campus (RHCC) database system. Respectively, 2351 and 1021 patient records were included in the analysis and many features (demographics, clinical, lab tests, medical treatment and time-series variables, generated after collection) were considered, although not all the features were included in both databases. To avoid overfitting, an XGBoosting feature selection algorithm was applied to the two datasets. On each dataset (BIDCM and RHCC), previously split into a training subset and a validation subset, a version of the model was trained. The model was an ensemble of six RF models and two XGBoost models, tuned with different settings. The final result was provided by the soft voting method applied to the probability of the BSI outputted by each single algorithm. After conducting 10-fold cross-validation, the models were tested: the BIDCM model obtained an AUROC of 0.89 ± 0.01 and a Brier score of 0.037 (0.90 ± 0.01 and 0.047 considering a variation of the dataset), and the RHCC model obtained an AUROC of 0.92 ± 0.02 and 0.098 (0.93 ± 0.03 and 0.061), respectively. In comparison to the single ML models (LASSO, RF and GB tree (GBT)), the proposed model outperformed all the others. Finally, the authors performed an external validation, running one model on data from the other's database. They found that the AUROCs deteriorated: the AUROC was 0.59 ± 0.07 for BIDMC and 0.60 ± 0.06 for RHCC. Although many variables were different between the databases, that was not the reason for the loss of performance.

The Sars-CoV-2 pandemic and the global unpreparedness to address it was an important stimulus for identifying a new way to face the associated problems; for example, the difficulty of having specific tests drove the medical community to look for new approaches. Yang et al. [44] evaluated 3356 eligible patients. They constructed a 685-dimensional vector made of laboratory tests results for each patient, reducing it to a 33-dimension vector (27 lab analysis, age, gender and ethnicity), according to the results of the univariate analysis that was performed to assess the association with the real-time reverse transcriptase polymerase chain reaction (RT-PCR) result (considered ground truth for positiveness to SARS-CoV-19). Four ML models were trained considering these features (logistic regression, DT, RF, gradient boosting decision tree (GBDT)), and they were evaluated in two different settings. The best performance was obtained by GBDT (AUC = 0.854, 95% confidence interval (CI) 0.829-0.878) in the first setting, while in the second setting, the AUC was 0.838. Using the Shapley additive explanations technique, the authors found that the most important variables for the model were lactic acid dehydrogenase (LDH), C-reactive protein (CRP) and ferritin.

Ye et al. [43] developed and validated a real-time early warning system (EWS) designed to predict patients at high risk of mortality in order to assist clinical decision making and to enable clinicians to focus on high-risk patients before the acute event. First, the observation window, called "inpatient day", was set (24 h), and 680 predictors were chosen among the historical medical variables and clinical information. Two different cohorts were involved in the study. The first was a retrospective cohort consisting of 42,484 patients, and it was used to build the models and compare them. RF, XGBoost, Boosting, SVM, LASSO and KNN were the models chosen to predict the outcomes, and their PPVs were used to calculate the risk score of mortality and to determine the thresholds of risk. The second cohort, a prospective one consisting of 11,762 patients, was involved to prospectively evaluate the EWS. RF was the selected method because it obtained the highest c-statistic (0.884). A risk score was assigned to each observation window (inpatient day), and then these were stratified. Considering high-risk patients, EWS achieved a sensitivity of 26.7% (68/255 death patients) and a PPV of 69%, successfully alerting clinicians from 24-48 h to 7 days before the death of 68 out of 99 of the high-risk patients. Comparing EWS with Vital-PAC early warning score (ViEWS), a common warning score, this latter was outperformed, since it showed a c-statistic of 0.764, sensitivity of 13.7 and a PPV of 35%. Considering both high-and intermediate-risk patients, the new EWS was better. Finally, applying the Gini index, 349 predictors strongly associated with the outcome were recognised, and they included the expected cardiovascular disease, congestive heart failure or renal disease, but curiously, also emergency department visits, inpatient admissions and the clinical costs incurred over the previous 12 months.

A stimulating field of investigation is represented by the ability of ML models to predict laboratory test values without performing them. Yu et al. [49] developed a neural network model with the aim of reducing the number of tests performed, losing only a small percentage of accuracy. Using data from 12 lab tests obtained from the MIMIC-III dataset, they trained their models, which consisted of two modules. The first module predicted the laboratory result, while the second predicted the probability, according to a threshold, that the test would be conducted. The best model was the one that considered not only the lab test but also the demographic, vital signs and an encoding indicating missing values. Given the definition of "accuracy" as the proportion of concordant pairs between the predicted state and the observed state (normal/abnormal), it was found that the model using a 33% reduction in the number of tests was able to maintain an accuracy of more than 90%, while the model using a 15% reduction was able to maintain an accuracy of more than 95%.

Many patients that required haemodialysis and received erythropoiesis-stimulating agents (ESA) due to end-stage renal diseases, experience the haemoglobin (Hgb) cycling phenomenon. Data from 1972 patients allowed Lobo et al. [53] to develop a recurrent neural network (RNN) that used historic data, future ESA and iron dosing data to predict the trajectory and the Hgb levels within the following 3 months. Among the patient characteristics, dialysis data, dosing of ESA and laboratory tests (haemoglobin and iron included), 34 variables were chosen by nephrologists and after close examination of the literature. A three-module neural network model was then built. The first module, an RNN-long short-term memory (RNN-LSTM), was used to compute the history of patients as a weekly time series. The second module, a regular neural network, elaborated the static data. The third module, another RNN-LSTM, encompassed the future weekly doses of ESA and iron over the forecasting horizon. In addition to the variables, the weekly time series for clinical events was added and seven parameters were used to make different combinations. Due to the three different forecasting horizons (1, 2 and 3 months), 960 different models were trained. As expected, the greater the number of months that were included in the history, the better the performance. Similarly, the performances were better when a near forecast was asked of the model. In contrast to commonly held beliefs, the best performances were obtained from the models that used a small number of features and a smaller version of the model. In fact, the best performance was obtained by the model that analysed 5 months of data and had its forecasting horizon set at 1 month, used less features and a simpler network. Its mean absolute error (MAE) was 0.527 and its mean squared error (MSE) was 0.489. The authors reported that running the model without the future iron dosing information allowed them to obtain comparable results. Moreover, they claimed to have provided a system that can predict the trend of haemoglobin according to the therapy in order to allow clinicians to forecast what would happen if they did or did not administer the planned therapy.

The aim of the study conducted by Voglis et al. [61] was to evaluate whether an ML model could predict postoperative hyponatremia (i.e., serum sodium < 130 mmol/L within 30 days after surgery) after resection of pituitary lesions. A total of 26 features (laboratory findings and from pre-and post-operative MRI results) from the data of 207 patients were used to train and test four different ML models: generalized linear model (GLM), GLMBoost, NB classifier and RF. For the missing data, a KNN algorithm was used. During the validation, the GLMBoost model delivered the best performance with an AUROC of 67.1, an F1 score of 40.6%, a PPV of 35.3 and an NPV of 82.5. The NB model obtained the best sensitivity (73.4 vs 47.8), and RF had the best accuracy (69.3 vs 67.7). Only GLMBoost was run on the testing dataset, showing an AUROC of 84.3% (95% CI 67.0-96.4) and an accuracy of 78.4% (95% CI 66.7-88.2). The sensitivity was 81.4%, the specificity was 77.5% and the F1 score was 62.1%. Due to the low prevalence of the condition in the patient population, this last model obtained a high NPV (93.9%) but a low PPV (50%). Assessing the loss in performance of the model when each variable was rejected, the most important features were identified: preoperative serum prolactin, preoperative serum insulin-like growth factor 1 level (IGF-1), body mass index (BMI) and preoperative serum sodium level. Ye et al. [51] compared the performance of many ML models and logistic regression for predicting gestational diabetes (GDM) using routine lab tests. They chose 104 variables (medical history, clinical assessment, ultrasonic screening data, biochemical data and data from Down's screening), and they included 22,242 women in the study. Eight ML models (GBDT, AdaBoost, light gradient boosted (LGB), Vote, extreme gradient boosted (XGB), RF, DT, ML logistic regression) and two conventional logistic regression models were trained, tested and compared. Concerning discrimination, GDBT was the best performer among the ML models, although the logistic regression model was found to have a similar AUC (73.51%, 95% CI 71.36%-75.65% vs 70.9%, 95% CI 68.68%-73.12%). In terms of calibration, GDBT was the second-best performer after DT. According to the GBDT model, fasting blood glucose, glycated haemoglobin, triglycerides and maternal body mass index (BMI) were the most important predictors, while HDL and glycated haemoglobin were the most important, according to the logistic regression model. In the GBDT model, the authors identified 0.3 as the point to predict the absence of GDM with an NPV of 74.1 (95% CI 69.5%-78.2%) and a sensitivity of 90% (95% CI 88.0%-91.7%), and they identified 0.7 as the point to predict the presence of GDM with a PPV of 93.2% (95% CI 88.2%-96.1%) and a specificity of 99% (95% CI 98.2%-99.4%). According to the authors, the ML models did not outperform the conventional logistic regression models. The performance of all the other models was similar to that of the DL model. Both DL and CPH were in agreement about the importance of blood urine nitrogen (BUN), albumin and creatinine for PFS prediction, BUN for OS prediction, while only the DL model used white blood cell (WBC) count, platelets, bicarbonate and haemoglobin for PFS and bicarbonate for OS, surprisingly omitting albumin, creatinine and platelets, which were used by the CPH model. Given the omission of albumin, a well-recognised prognostic factor, the authors expressed their concern about the reliability of the model.

Aydin et al. [59] considered data from 7244 patients to develop a simple algorithm for preoperative diagnosis of appendicitis in children. They trained six ML models (NB, KNN, SVM, DT, RF and generalised linear model) and tested them. Although DT was not the best performer (the AUC was 93.97 for DT vs 99.67 for RF), it was the model they were looking for because it was simple, easy to interpret and familiar to clinicians. It also provided a clear interpretation of the importance of the variables: platelet distribution width (PDW), WBC count, neutrophils and lymphocytes were the most important factors for detecting appendicitis in patients. In the analysis to assess whether the DT model was able to differentiate patients with complicated appendicitis, its performance further decreased (AUC of 79.47%, accuracy of 70.83, sensitivity of 66.81%, specificity of 81.88%).

The goal of the study conducted by Daunhawer et al. [39] was to predict, after each bilirubin measurement, if a neonate would develop an excessive bilirubin level in the next 48 h. Toward that end, 44 variables from 362 neonates were used to assess three different models: a LASSO model (L-1 regularized logistic regression), an RF model and a model that combined the predictions of the previous two. The combined model had an AUC of 0.592 ± 0.013, while the LASSO and RF models had an AUC of 0.947 ± 0.015 and 0.933 ± 0.019, respectively. RF, a backward selection, and LASSO were also used to identify gestational age, weight, bilirubin level and hours since birth, and they were found to suffice for a strong predictive performance, as the most strongly associated variables. The authors developed an online tool using the best performing model, and they validated it on an external dataset, thus obtaining a better AUROC (0.954).

In Jeong et al. [25] , the problem of identifying and evaluating adverse drug reactions was addressed using a ML model that integrates already existing algorithms based on electronic health record (EHR). From the Ajou University Hospital EHR dataset, the European Union Adverse Drug Reactions from Summary of Product Characteristics (EU-SPC database) and Side Effect Resource (SIDER) 4.1, a resource of side effects extracted from drug labels, they made an adverse drug reaction (ADR) reference dataset of 1674 drug-event pairs (778 with known associations and 896 with unknown associations). The outputs and intermediates of Comparison of Extreme Laboratory Test (CERT), Comparison of Extreme Abnormality Ratio (CLEAR) and Prescription pattern Around Clinical Event (PACE) algorithms (18, 25 and 5, respectively) were extracted and used as features for four ML models, more precisely, L1 regularized logistic regression, RF, SVMs and NNs. The performances of older algorithms (i.e., CLEAR, CERT400, CCP2) were then compared to the average performance of each ML model, which were evaluated based on 10 experiments with a 10-fold cross-validation for each model. The ML algorithm outperformed the other algorithms. The F-scores and the AUROCs of the ML models were 0.629-0.709 and 0.737-0.816 respectively, instead of 0.020-0.597 and 0.475-0.563 respectively, from the older methods. RF had the highest AUROC and PPV (0.727 ± 0.031), while NN the highest sensitivity (0.793 ± 0.062), NPV (0.777 ± 0.052) and F-scores (0.709 ± 0.037). SVM had the highest specificity (0.796 ± 0.046). By using the Gini index in the RF model and the magnitude of coefficient in the L1 regularized logistic regression model, they found that the most important features were related to the shape of the distribution and the descriptive statistics of laboratory result tests.

Kirk et al. [55] used data from 996 patients to assess if the integration of routine postoperative data in a predictor model of 30-day readmission after cystectomy could improve its predictive performance. Demographic, laboratory-related and complicationrelated variables were considered, and a SVM model was used to define the daily (1 to 7 days after discharge) cut-offs to distinguish between readmitted and non-readmitted patients. Multiple logistic regression models were trained using different combinations of variables and thresholds from SVM, and clinical data were used to examine the effects on readmission risk. The most discriminative values were WBC, bicarbonate, BUN and creatinine, whereas BUN, WBC, total bilirubin and chloride showed greater variance in the readmitted patients than in the non-readmitted ones. Among the models, the best performance was obtained from the one that included all the variables, the SVM thresholds and postoperative complications (AUC = 0.62); however, by adding lab test thresholds, it was possible to improve the performance (AUC of 0.59 for the SVM model vs AUC of 0.52 for the previous model). Finally, using the same variables that were used in the best-performing model, the authors also trained an RF regression model that achieved an AUC of 0.68.

In the previous literature review [1] , 37 papers (published between 2007 and 2017) were found, of which only three were indexed by the MEDLINE database. In the review presented here, we found 44 articles, with a significant yearly increase: from six articles in 2017 to 18 in the first 8 months of 2020. Although this can be interpreted as a sign of growing interest, it should be noted that almost all of the articles were retrospective studies, with two exceptions [43, 56] .

As seen in the previous section, the models based on decision trees were the most popular. In particular, the RF model was selected by several authors [18, 22, 29, 34, 38, 42, 43, 47, 48, 50, 55] , while DTs were only chosen in two relevant studies [24, 59] . This could be due to a variety of reasons, such as the generally very good performance of this class of models, and because of their interpretable output, especially when this is enriched with estimates of the most relevant variables expressed in terms of the Gini impurity index. However, clarity and simplicity are the reasons why logistic regression was also frequently chosen [36, 56] , both as a stand-alone model and also as a baseline model to be compared with other, more complex (and hence less generalisable) models. Among the best models, those in the Ensemble family (e.g., XGB, GBT) were chosen both for their medium-high performance [21, 30, 32, 33, 44, 51, 58, 61] and their training speed. Models in the DL family [27, 35, 37, 49, 52, 53, 60] , especially RNN and ANN, have been increasingly chosen in recent years. The advantage of these systems is their potential in terms of performance, although the resources (time and the amount of data) required for training are reported to be higher for DL models than traditional ML models. RNN, and in particular RNN-LSTM, was used by several authors [27, 52, 53] to integrate the temporal patterns between the variables.

We can observe an evolution in the chronological accumulation of the studies considered in this review. In fact, there has been an increasing use of comparative analysis between different models with the aim of identifying the best performing model, whenever possible. This practice was not often observed before 2017, and it was seen less frequently in the first years covered by the present review than it was in 2019 and 2020, when many authors preferred to report the performance of a single algorithm, at most compared with a baseline model like logistic regression [22, 26, 29, [39] [40] [41] 52, 56] .

It is interesting to dig deeper into the purposes for which ML has been used in these studies. Although the objective of the surveyed studies was mostly "detection", that is, to answer a dichotomous question, such as whether the laboratory test is associated with either a positive or negative case or with an abnormal or normal biochemical phenotype, the authors reported a number of reasons for developing and proposing an ML approach to this class of task. One of the most frequent reasons reported was the need for systems that can predict complex conditions or outcomes more efficiently (or less costly) than is possible with longer and more expensive investigations, such as routine laboratory tests and vital parameters [23, 38, 54, 56, 58] . However, some authors [18, 24, 27, 35, 39, 44] focused on the possibility of predicting or estimating the risk of certain outcomes or complications. Only rarely, and notably in Reference [43] , was the impact of this anticipation evaluated, leading to interesting results, as reported in the article about internal medicine. Moreover, other authors [32, 33] have dealt with how to reduce the number of analyses required to reach a conclusion through an accurate prediction of the test results, or they have assessed how to improve therapeutic protocols with complex patients [22, 24, 53] . Moreover, procedural problems affecting laboratory medicine, such as wrong blood in tube errors and implausible values, were analysed [26, 40] . In the majority of studies, the most important variables for the models were explicitly reported. Interestingly, the variable's importance for the model did not necessarily correlate with its biological or clinical relevance, suggesting that further research is needed to determine the potential hidden and non-trivial associations between the variables and the outcome [25, 28, 41] .

In their conclusions, many of the authors suggested the opportunities associated with the ML approach, and some have also made their algorithms available [24, 34, 39, 56] ; however, the scarcity of articles following a prospective design shows that the interest in ML is still more academic than practical. In fact, as noted at the beginning of this article, only seven of the AI systems concerning laboratory medicine have been approved by the FDA in the last three years. This led us to believe that enthusiasm for ML is still being dampened by the need to confront the difficulties of building valid and robust models that could prove to be of use in real-world applications.

However, the lack of prospective studies can result in a lack of evaluations of the impact of ML in real-world practice; in turn, this can reduce the benefits of using ML [64] . This can occur for several reasons. Generally, it costs more to conduct prospective studies than retrospective studies. This is due to organisational reasons, data collection and cleansing, the involvement of patients and their higher risk of failure. In the context of ML, the validation on external or prospective datasets may not yield the expected results. This is true especially if the training and testing populations are different, if the model is affected by overfitting or if it has been generated in a controlled environment, hence not in real-world settings. As seen in the results, external validation is not performed regularly [65] . Even when external validation is conducted, the results are drastically inferior to the performance reported with an internal validation set [54] .

However, we believe that the external validation of a model is an essential step to obtain useful tools, and it is even more necessary if the dataset is collected prospectively. Therefore, to replicate the findings reported in the studies included in this literature review, one could alternatively identify the groups of patients on whom the model is expected to work and limit its application to these subjects. A further possible reason for the relatively low number of prospective studies is the lack of bridging figures between the medical field and the information technology (IT) field. In the past 5 years, this need has led to the creation of master's degrees that provide the basic knowledge of both biomedical engineering and medical surgery.

It follows that the choice to build an ML system is not a shortcut to obtain simpler and better results in comparison to conventional methods [51] . A good ML system requires an adequate amount of data, the right quality of the data and valid management of the missing values (i.e., data imputation), a reasoned pre-selection of the variables to input into the system and the right use of the training set, validation (or tuning) set and testing set. For instance, the articles we analysed involved a varying number of patients, ranging from populations of dozens of patients to tens of thousands. However, especially for ML systems that require large amounts of training data (e.g., DL), it is essential to utilise large amounts of complete data. Not surprisingly, intensive care and "pure" laboratory medicine were the two medical specialities that were associated with the most articles. In these two areas, it is easier to collect large amounts of data and have them available in a machine-readable format. In intensive care unit settings, this is the case because the admitted patients are usually closely monitored; in laboratory settings, this is because different machineries and modalities produce data for almost all other areas of medicine that rely on blood-related specimens.

The choice of input variables is another important aspect of a successful ML model. While DL techniques allow the use of a large number of variables because their selection and engineering are fully automated (by the input layers of ANNs), other systems are used to find the most important variables in order to focus on them [20, 21, 28, 45, 57] . Over time, what kind of variables to use is becoming clearer: it has evolved from only using static data to using simple or more complex time-related representations [27, 30, 48, 54] , which also require novel ways to manage data incompleteness and to leverage this as an indirect source of information about the patient's condition [36] . In this regard, some authors [19, 51] , in light of their disappointing results, have invited the medical specialist community to choose, include and study the new predictors.

Dealing with missing data can be challenging [23] ; toward that end, many different apparently effective techniques have been proposed and tested in the last 3 years [66] [67] [68] [69] . Nevertheless, it was rare to see these techniques mentioned in the articles that were reviewed here. In 2017, it was observed that the lack of cross-citations among authors dealing with ML in orthopaedics should not be considered to be a sign of dispersion of the community of scholars who are active in ML [8] ; rather, it was viewed as a sign of its heterogeneity. In light of our systematic review, we can make a similar statement by also extending it to the authors mentioned in the literature review presented in this article.

In this context, sharing the training data, even in an anonymised form, and the training details (e.g., hyperparameters, procedures of standardisation and normalisation, procedures to cope with data scarcity like k-fold cross-validation [70, 71] ), and hence adherence to standards for reporting ML studies properly and comprehensively (such as TRIPOD-ML [72] and CONSORT-AI [73] ), is extremely important in order to enable and facilitate the reproducibility of the results and their external validation.

In spite of the partial disillusionment of some authors [65] , the articles included in this review suggest that the trend toward using ML in the field of medicine will continue in the coming years. Precision (or tailored) medicine, such as the possibility to calibrate thresholds and pathological states on subjects rather than on populations [74] , is a common goal of the laboratory medicine community, due to the significant amount of data available from haematochemical analysis. However, for these algorithms to be applied to daily clinical practice, we are aware that greater rigor is needed to validate clinical studies (also by applying new guidelines) and more resources are needed to create genuinely multidisciplinary research groups and to conduct more prospective studies, which could also involve more patients and a greater variety of patients.

There are a few limitations to the systematic review we conducted and reported in this article. We chose a simple but comprehensive search query, consisting of words commonly used in the area we intended to study. However, we did not use synonyms and we did not include words that are typical of subthemes or overtly technical jargon. We also only used PubMed and Scopus to conduct our search, since these are considered to be the two main academic literature indexing services.

Academic enthusiasm for ML in laboratory medicine is real and it is increasing. However, unlike other disciplines, laboratory medicine has not yet seemed to have embraced this perspective [5] . To determine whether the number of works applying ML to laboratory medicine has flooded the proverbial basement of this medical field, we can conclude that the flood level has certainly begun to rise, but we are still waiting for it to form a lake of consolidated knowledge and reliable tools for clinical practice. 

Machine learning in laboratory medicine: Waiting for the flood?

Automation and artificial intelligence in the clinical laboratory

A short guide for medical professionals in the era of artificial intelligence

Collaborative AI and Laboratory Medicine integration in precision cardiovascular medicine

Dark Daily Information

A survey on Data Mining approaches for Healthcare

Artificial Intelligence and Machine Learning in Pathology: The Present Landscape of Supervised Methods. Acad

Data science, artificial intelligence, and machine learning: Opportunities for laboratory medicine and the value of positive regulation

Predicting the Future-Big Data

A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models

Unintended Consequences of Machine Learning in Medicine

Errors in search strategies used in systematic reviews and their effects on information retrieval

Using grounded theory as a method for rigorously reviewing literature

Early hospital mortality prediction of intensive care unit patients using an ensemble learning approach

Prediction of recurrent clostridium difficile infection using comprehensive electronic medical records in an integrated healthcare delivery system

Enhancement of hepatitis virus immunoassay outcome predictions in imbalanced routine pathology data by data balancing and feature selection before the application of support vector machines

Machine Learning Algorithms for Risk Prediction of Severe Hand-Foot-Mouth Disease in Children

Novel Risk Assessment Tool for Immunoglobulin Resistance in Kawasaki Disease: Application Using a Random Forest Classifier: Application Using a Random Forest Classifer

Supervised learning for infection risk inference using pathology data

Applied Informatics Decision Support Tool for Mortality Predictions in Patients With Cancer

Machine learning model combining features from algorithms with different analytical methodologies to detect laboratory-event-related adverse drug reaction signals

Using machine learning-based multianalyte delta checks to detect wrong blood in tube errors

An Interpretable ICU Mortality Prediction Model Based on Logistic Regression and Recurrent Neural Networks with LSTM units

High-density lipoprotein cholesterol levels and pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension

Development and Validation of Machine Learning Models for Prediction of 1-Year Mortality Utilizing Electronic Medical Record Data Available at the End of Hospitalization in Multicondition Patients: A Proof-of-Concept Study

Predicting the risk of emergency admission with machine learning: Development and validation using linked electronic health records

Analyte Quantity Detection from Lateral Flow Assay Using a Smartphone

Prevalence and Predictability of Low-Yield Inpatient Laboratory Diagnostic Tests

Using artificial intelligence to reduce diagnostic workload without compromising detection of urinary tract infections

Interactive Machine Learning for Laboratory Data Integration

Early prediction of acute kidney injury following ICU admission using a multivariate panel of physiological measurements

A new insight into missing data in intensive care unit patient profiles: Observational study

Survival outcome prediction in cervical cancer: Cox models vs deep-learning model

Relative criticalness of common laboratory tests for critical value reporting

Enhanced early prediction of clinically relevant neonatal hyperbilirubinemia with machine learning

A clustering approach for detecting implausible observation values in electronic health records data

Modelling outcomes after paediatric brain injury with admission laboratory values: A machine-learning approach

Automatic machine-learning-based outcome prediction in patients with primary intracerebral hemorrhage

A Real-Time Early Warning System for Monitoring Inpatient Mortality Risk: Prospective Study Using Electronic Medical Record Data

Routine laboratory blood tests predict SARS-CoV-2 infection using machine learning

Development and validation of prognosis model of mortality risk in patients with COVID-19

Exploration of critical care data by using unsupervised machine learning

Predicting adverse outcomes for febrile patients in the emergency department using sparse laboratory data: Development of a time adaptive model

Temporal Pattern Detection to Predict Adverse Events in Critical Care: Case Study With Acute Kidney Injury

Predict or draw blood: An integrated method to reduce lab tests

Machine learning can predict survival of patients with heart failure from serum creatinine and ejection fraction alone

Comparison of Machine Learning Methods and Conventional Logistic Regressions for Predicting Gestational Diabetes Using Routine Clinical Data: A Retrospective Cohort Study

Mortality prediction enhancement in end-stage renal disease: A machine learning approach

A recurrent neural network approach to predicting hemoglobin trajectories in patients with End-Stage Renal Disease

Early diagnosis of bloodstream infections in the intensive care unit using machine-learning algorithms

Dynamic readmission prediction using routine postoperative laboratory results after radical cystectomy

A Machine Learning-Based Model to Predict Acute Traumatic Coagulopathy in Trauma Patients Upon Emergency Hospitalization

Improved prediction of dengue outbreak using combinatorial feature selector and classifier based on entropy weighted score based optimal ranking

Using a machine learning approach to predict mortality in critically ill influenza patients: A cross-sectional retrospective multicentre study in Taiwan

A novel and simple machine learning algorithm for preoperative diagnosis of acute appendicitis in children

Identification of risk factors for patients with diabetes: Diabetic polyneuropathy case study

Feasibility of machine learning based predictive modelling of postoperative hyponatremia after pituitary surgery

Artificial intelligence-based tools to control healthcare associated infections: A systematic review of the literature

A Review of Predictive Analytics Solutions for Sepsis Patients

How to develop machine learning models for healthcare

Time to reality check the promises of machine learning-powered precision medicine

3D-MICE: Integration of cross-sectional and longitudinal imputation for multianalyte longitudinal clinical data

A Combined Interpolation and Weighted K-Nearest Neighbours Approach for the Imputation of Longitudinal ICU Laboratory Data

Imputation of Missing Data in Electronic Health Records Based on Patients' Similarities

Predicting Missing Values in Medical Data Via XGBoost Regression

No unbiased estimator of the variance of k-fold cross-validation

Sensitivity analysis of k-fold cross validation in prediction error estimation

Extension of the CONSORT and SPIRIT statements

Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: The CONSORT-AI Extension

Diagnostics 4.0: The medical laboratory in digital health

Abbreviations used in Tables 1 and 2